Bronte Capital Management Pty

Bronte Capital Management Pty as of Sept. 30, 2021

Portfolio Holdings for Bronte Capital Management Pty

Bronte Capital Management Pty holds 27 positions in its portfolio as reported in the September 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ishares Tr Russell 2000 Etf Call Option (IWM) 25.2 $344M 156k 2204.37
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY) 13.4 $183M 42k 4307.55
Ishares Tr Rus 2000 Grw Etf Call Option (IWO) 9.9 $136M 463k 293.59
Alphabet Cap Stk Cl A (GOOGL) 9.6 $132M 49k 2673.52
Berkshire Hathaway Inc Del Cl B New (BRK.B) 8.3 $114M 417k 272.94
Herbalife Nutrition Com Shs (HLF) 7.3 $99M 2.3M 42.38
Regeneron Pharmaceuticals (REGN) 5.5 $75M 124k 605.18
Interactive Brokers Group Com Cl A (IBKR) 4.0 $54M 869k 62.34
Visa Com Cl A (V) 2.9 $40M 177k 222.75
Corteva (CTVA) 2.6 $36M 860k 42.08
Bank of New York Mellon Corporation (BK) 1.9 $26M 498k 51.84
State Street Corporation (STT) 1.7 $23M 269k 84.72
Alphabet Cap Stk Cl C (GOOG) 1.4 $19M 7.0k 2665.38
Graham Hldgs Com Cl B (GHC) 1.1 $15M 25k 589.16
Altria (MO) 1.0 $13M 288k 45.52
Beyond Meat Put Option (BYND) 0.8 $11M 100k 105.26
General Mills (GIS) 0.7 $10M 169k 59.82
Philip Morris International (PM) 0.7 $10M 106k 94.79
Sotera Health (SHC) 0.3 $4.7M 179k 26.15
Mondelez Intl Cl A (MDLZ) 0.3 $4.6M 80k 58.18
Newmont Mining Corporation (NEM) 0.3 $4.0M 73k 54.31
Bath &#38 Body Works In (BBWI) 0.3 $3.8M 60k 63.03
Vir Biotechnology (VIR) 0.2 $3.3M 75k 43.53
Merrimack Pharmaceuticals In Com New (MACK) 0.2 $2.7M 549k 4.83
EnPro Industries (NPO) 0.2 $2.6M 30k 87.13
Biontech Se- Sponsored Ads (BNTX) 0.1 $1.9M 6.8k 272.99
Decibel Therapeutics 0.1 $1.2M 160k 7.71